Protein Kinase C Function in Muscle, Liver, and β-Cells and Its Therapeutic Implications for Type 2 Diabetes

  1. Carsten Schmitz-Peiffer and
  2. Trevor J. Biden
  1. From the Garvan Institute of Medical Research, Darlinghurst, Australia
  1. Corresponding author: Trevor J. Biden, t.biden{at}garvan.org.au

Increased lipid availability is strongly associated with both β-cell dysfunction and insulin resistance, two key facets of type 2 diabetes. Isoforms of the protein kinase C (PKC) family have been viewed as candidates for mediating the effects of fat oversupply because they are lipid-dependent kinases with wide-ranging roles in signal transduction, including the positive and negative modulation of insulin action. Until recently, their involvement was based on correlative studies, but now causative roles for distinct PKC isoforms have also been addressed, in both pancreatic β-cells and insulin-sensitive tissues. Our goal here, therefore, is to review the hitherto disparate fields of PKC function in insulin signaling/resistance on the one hand and in regulating β-cell biology on the other hand. By integrating these two areas, we provide a reappraisal of the current paradigm regarding PKC and type 2 diabetes. In particular, we propose that PKCε warrants further investigation, not merely as a treatment for insulin resistance as previously supposed, but also as a positive regulator of insulin availability.

DIACYLGLYCEROL-MEDIATED ACTIVATION OF PROTEIN KINASE C

The protein kinase C (PKC) family comprises 10 isoforms that have been subdivided into three groups (Fig. 1) based on sequence homology and mechanisms of activation (rev. in 1). While differentiated by their sensitivity to Ca2+, both the conventional PKCs (cPKCα, -β, and -γ) and novel PKCs (nPKCδ, -ε, -η, and -θ) are dependent on diacylglycerol (DAG) for full activation. These isoforms are therefore responsive to the stimulation of G protein–coupled receptors or receptor tyrosine kinases, which activate phospholipase C, inducing the hydrolysis of phosphatidylinositol 4,5-bisphosphate at the plasma membrane and the resultant generation of DAG and Ca2+. Evidence for the acute elevation of DAG in this fashion by insulin was reported in early studies (2), although the identities of the putative phospholipase(s) and phospholipid substrates involved were never clarified. …

| Table of Contents